INSIGHTS ON CLINICAL TRIAL DESIGN
-
Where Study Simulation Fits In Clinical Trials
Simulation lets teams test assumptions early, showing how design and operations affect timelines, cost, and feasibility — reducing risk and enabling confident, data‑driven decisions.
-
The Path Forward In Oncology Trials
A comprehensive site support model is crucial for navigating the complexities of modern oncology trials and accelerating drug development.
-
Executing A Complex Global Breast Cancer Trial In A Rapidly Evolving Treatment Landscape
See how rapid site activation, strong oncology site relationships, and adaptive protocol management kept a complex global cancer trial on track amid evolving standards of care.
-
Digital Physical Activity Measures In Phase 3 Immunology Trials
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
-
Early Oncology Clinical Trials: Key Considerations To Plan For Success5/14/2025
This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.
-
Decentralized And Community-Based Solutions Driving Women's Healthcare9/24/2025
Clinical trials should reflect the affected population by reducing participation barriers and bringing trials to patients to increase inclusion and improve real-world data.
-
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove A Drug Works5/22/2026
PTSD trials expose one of the hardest problems in modern drug development, a reliance on clinician-administered and patient-reported scales to determine whether a therapy truly works.
-
How Pharmaceutical Companies Can Effectively Engage With PAOs2/11/2025
Experts explain the role of Patient Advocacy Organizations (PAOs), tips for pharmaceutical companies and PAOs to forge strong relationships, and techniques to integrate patient perspectives.
-
Why Clinical Trial Demographics Don't Match Real-World Populations12/4/2025
Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Automate protocol design, database builds, and validation to cut study setup from months to days — enabling faster analytics, earlier insights, and trial simulation.
-
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
-
Expert Support for Clinical Research and Research Administration
-
Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.
-
With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.